Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2015
Design and optimization of selective azaindole amide M1 positive allosteric modulators
Jennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.
Journal of Medicinal Chemistry
|
June 9, 2016
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Jennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.
Journal of Medicinal Chemistry
|
April 24, 2015
The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)
Christopher L Shaffer, Nandini C Patel, Jacob Schwarz, et al.
Journal of Medicinal Chemistry
|
January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator
Lei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Journal of Medicinal Chemistry
|
August 18, 2017
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates
Antonia F Stepan, Michelle M Claffey, Matthew R Reese, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2015
Design and optimization of selective azaindole amide M1 positive allosteric modulators
Jennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.
Journal of Medicinal Chemistry
|
June 9, 2016
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Jennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.
Journal of Medicinal Chemistry
|
April 24, 2015
The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)
Christopher L Shaffer, Nandini C Patel, Jacob Schwarz, et al.
Journal of Medicinal Chemistry
|
January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator
Lei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Journal of Medicinal Chemistry
|
August 18, 2017
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates
Antonia F Stepan, Michelle M Claffey, Matthew R Reese, et al.
Page
of 3